Young Cw
Impact in
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 5
- Oncology 8
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- Raymond P. Warrell (5 shared papers)M. Earl Balis (1 shared paper)Gerald Schochetman (1 shared paper)Burchenal Jh (4 shared papers)Edward Miller (2 shared papers)Z A Arlin (3 shared papers)B Clarkson (1 shared paper)Sanford Jay Kempin (2 shared papers)
- Journals
- PubMed (26 papers)
- Partner nations
- United States
In The Last Decade
Young Cw
25 papers receiving 389 citations
Peers
Comparison fields: 5 of 60
- Oncology 127
- Hematology 57
- Toxicology 17
- Molecular Biology 182
- Biochemistry 18
Countries citing papers authored by Young Cw
This map shows the geographic impact of Young Cw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Cw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Cw more than expected).
Fields of papers citing papers by Young Cw
This network shows the impact of papers produced by Young Cw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Cw. The network helps show where Young Cw may publish in the future.
Co-authors
The 25 scholars most cited alongside Young Cw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of DNA synthesis by hydroxyurea: structure-activity relationships. | 1967 | 89 |
| 2 | The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine). | 1960 | 51 |
| 3 | Phase I trial of homoharringtonine administered as a 5-day continuous infusion. | 1983 | 29 |
| 4 | Application of biochemical modulation with a therapeutically inactive modulating agent in clinical trials of cancer chemotherapy. | 1985 | 26 |
| 5 | Phase I study of 6-diazo-5-oxo-L-norleucine (DON). | 1980 | 25 |
| 6 | Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside. | 1979 | 24 |
| 7 | Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. | 1981 | 23 |
| 8 | Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. | 1982 | 23 |
| 9 | The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report. | 1960 | 22 |
| 10 | Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. | 1986 | 22 |
| 11 | Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II). | 1980 | 20 |
| 12 | Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia. | 1982 | 20 |
| 13 | Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU). | 1985 | 20 |
| 14 | Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung. | 1981 | 12 |
| 15 | Phase I trial of PALA. | 1980 | 11 |
| 16 | Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma. | 1981 | 11 |
| 17 | Phase II evaluation of pyrazofurin in patients with carcinoma of the lung. | 1978 | 10 |
| 18 | Comparative aspects of the pharmacology of the antimetabolites. | 1967 | 9 |
| 19 | Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule. | 1980 | 9 |
| 20 | Modulation of 5-FU action by thymidine in murine and human tumors. | 1981 | 8 |
About Young Cw
Young Cw is a scholar working on Hematology, Oncology, Molecular Biology, Toxicology and Pathology and Forensic Medicine, having authored 26 papers that have together received 486 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Colorectal Cancer Treatments and Studies (6 papers), Acute Myeloid Leukemia Research (5 papers), Biochemical and Molecular Research (5 papers), Lung Cancer Treatments and Mutations (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (127 citations), Hematology (57 citations), Toxicology (17 citations), Molecular Biology (182 citations) and Biochemistry (18 citations). Young Cw has collaborated with scholars based in United States. Frequent co-authors include Raymond P. Warrell, M. Earl Balis, Gerald Schochetman, Burchenal Jh, Edward Miller, Z A Arlin, B Clarkson, Sanford Jay Kempin, Gordon B. Magill and Robert B. Sklaroff. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.